Methods for Estimating the Case Fatality Ratio for a Novel, Emerging Infectious Disease

Abstract During the course of an epidemic of a potentially fatal disease, it is important that the case fatality ratio be well estimated. The authors propose a novel method for doing so based on the Kaplan-Meier survival procedure, jointly considering two outcomes (death and recovery), and evaluate its performance by using data from the 2003 epidemic of severe acute respiratory syndrome in Hong Kong, People's Republic of China. They compare this estimate obtained at various points in the epidemic with the case fatality ratio eventually observed; with two commonly quoted, naïve estimates derived from cumulative incidence and mortality statistics at single time points; and with estimates in which a parametric mixture model is used. They demonstrate the importance of patient characteristics regarding outcome by analyzing subgroups defined by age at admission to the hospital.

[1]  G. Leung,et al.  A Tale of Two Cities: Community Psychobehavioral Surveillance and Related Impact on Outbreak Control in Hong Kong and Singapore During the Severe Acute Respiratory Syndrome Epidemic , 2004, Infection Control & Hospital Epidemiology.

[2]  Christophe Fraser,et al.  The Epidemiology of Severe Acute Respiratory Syndrome in the 2003 Hong Kong Epidemic: An Analysis of All 1755 Patients , 2004, Annals of Internal Medicine.

[3]  Christl A. Donnelly,et al.  SARS-CoV Antibody Prevalence in All Hong Kong Patient Contacts , 2004, Emerging infectious diseases.

[4]  V. Wong,et al.  Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak , 2004, Thorax.

[5]  T. Ng,et al.  Prevalence of subclinical infection by the SARS coronavirus among general practitioners in Hong Kong , 2004, Scandinavian journal of infectious diseases.

[6]  Y. Guan,et al.  Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings , 2004, Thorax.

[7]  W. Seto,et al.  Severe acute respiratory syndrome: scientific and anecdotal evidence for drug treatment. , 2004, Current opinion in investigational drugs.

[8]  J. Sung,et al.  Short-term outcome of critically ill patients with severe acute respiratory syndrome , 2004, Intensive Care Medicine.

[9]  L. Ho,et al.  The impact of community psychological responses on outbreak control for severe acute respiratory syndrome in Hong Kong , 2003, Journal of epidemiology and community health.

[10]  P. Hawkey,et al.  Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. , 2003, Journal of medical microbiology.

[11]  Y. Chan,et al.  Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS) , 2003, Thorax.

[12]  Arthur S Slutsky,et al.  Critically ill patients with severe acute respiratory syndrome. , 2003, JAMA.

[13]  Elizabeth Rea,et al.  Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. , 2003, JAMA.

[14]  Che-An Tsai,et al.  Clinical characteristics of fatal patients with severe acute respiratory syndrome in a medical center in Taipei. , 2003, Journal of the Chinese Medical Association : JCMA.

[15]  C. Fraser,et al.  Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong , 2003, The Lancet.

[16]  L. Poon,et al.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .

[17]  E. Fan.  SARS: Economic Impacts and Implications , 2003 .

[18]  J W Denham,et al.  A generalized F mixture model for cure rate estimation. , 1998, Statistics in medicine.

[19]  V. Farewell,et al.  The use of mixture models for the analysis of survival data with long-term survivors. , 1982, Biometrics.

[20]  D. Cox,et al.  THE ANALYSIS OF EXPONENTIALLY DISTRIBUTED LIFE-TIMES WITH Two TYPES OF FAILURE , 1959 .

[21]  C. Fraser,et al.  Seroprevalence of IgG antibody to SARS coronavirus (SARS-CoV) in a population-based sample of close contacts of all 1,755 cases in Hong Kong , 2004 .